Precyse: MedAssets sold to PE firm, will merge with Precyse

In a $2.7 billion deal, MedAssets, maker of revenue cycle and performance improvement tools, will be sold to Pamplona Capital, which will sell off one half of the company while merging the other with its Precyse subsidiary.According to Pamplona, the company would combine the RCM business for MedAssets with Precyse, a health information management company that Pamplona bought in July. The two companies already have run under a partnership agreement.Mergers & Acquisitionsread more